Drugs Health Pharma

FDA clears Asahi Kasei’s oral drug to treat herpes virus in immunodeficient

The US Food and Drug Administration has approved Asahi Kasei Therapeutics, Inc’s oral drug to treat mucocutaneous lesions caused by herpes simplex virus.

Read More